Po Yi Ho
Overview
Explore the profile of Po Yi Ho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Upton R, Banuelos A, Feng D, Biswas T, Kao K, McKenna K, et al.
Proc Natl Acad Sci U S A
. 2021 Jul;
118(29).
PMID: 34257155
Trastuzumab, a targeted anti-human epidermal-growth-factor receptor-2 (HER2) monoclonal antibody, represents a mainstay in the treatment of HER2-positive (HER2) breast cancer. Although trastuzumab treatment is highly efficacious for early-stage HER2 breast...
2.
Barkal A, Weiskopf K, Kao K, Gordon S, Rosental B, Yiu Y, et al.
Nat Immunol
. 2017 Nov;
19(1):76-84.
PMID: 29180808
Exciting progress in the field of cancer immunotherapy has renewed the urgency of the need for basic studies of immunoregulation in both adaptive cell lineages and innate cell lineages. Here...
3.
Chhabra A, Ring A, Weiskopf K, Schnorr P, Gordon S, Le A, et al.
Sci Transl Med
. 2016 Aug;
8(351):351ra105.
PMID: 27510901
Hematopoietic stem cell (HSC) transplantation can cure diverse diseases of the blood system, including hematologic malignancies, anemias, and autoimmune disorders. However, patients must undergo toxic conditioning regimens that use chemotherapy...
4.
Feng M, Chen J, Weissman-Tsukamoto R, Volkmer J, Ho P, McKenna K, et al.
Proc Natl Acad Sci U S A
. 2015 Feb;
112(7):2145-50.
PMID: 25646432
Macrophage-mediated programmed cell removal (PrCR) is an important mechanism of eliminating diseased and damaged cells before programmed cell death. The induction of PrCR by eat-me signals on tumor cells is...